369 related articles for article (PubMed ID: 24975321)
21. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes.
Thomson R; Molina-Portela P; Mott H; Carrington M; Raper J
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19509-14. PubMed ID: 19858474
[TBL] [Abstract][Full Text] [Related]
22. APOLs with low pH dependence can kill all African trypanosomes.
Fontaine F; Lecordier L; Vanwalleghem G; Uzureau P; Van Reet N; Fontaine M; Tebabi P; Vanhollebeke B; Büscher P; Pérez-Morga D; Pays E
Nat Microbiol; 2017 Nov; 2(11):1500-1506. PubMed ID: 28924146
[TBL] [Abstract][Full Text] [Related]
23. Genetics. Kidney disease is parasite-slaying protein's downside.
Leslie M
Science; 2010 Jul; 329(5989):263. PubMed ID: 20647431
[No Abstract] [Full Text] [Related]
24. Localization of serum resistance-associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei.
Bart JM; Cordon-Obras C; Vidal I; Reed J; Perez-Pastrana E; Cuevas L; Field MC; Carrington M; Navarro M
Cell Microbiol; 2015 Oct; 17(10):1523-35. PubMed ID: 25924022
[TBL] [Abstract][Full Text] [Related]
25. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
26. Drug transport and drug resistance in African trypanosomes.
Mäser P; Lüscher A; Kaminsky R
Drug Resist Updat; 2003 Oct; 6(5):281-90. PubMed ID: 14643298
[TBL] [Abstract][Full Text] [Related]
27. The human serum resistance associated gene is ubiquitous and conserved in Trypanosoma brucei rhodesiense throughout East Africa.
Gibson W; Backhouse T; Griffiths A
Infect Genet Evol; 2002 May; 1(3):207-14. PubMed ID: 12798017
[TBL] [Abstract][Full Text] [Related]
28. Expression and localization of serum resistance associated protein in Trypanosoma brucei rhodesiense.
Milner JD; Hajduk SL
Mol Biochem Parasitol; 1999 Nov; 104(2):271-83. PubMed ID: 10593181
[TBL] [Abstract][Full Text] [Related]
29. The trypanolytic factor-mechanism, impacts and applications.
Wheeler RJ
Trends Parasitol; 2010 Sep; 26(9):457-64. PubMed ID: 20646962
[TBL] [Abstract][Full Text] [Related]
30. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
31. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.
Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
Nat Med; 2006 May; 12(5):580-4. PubMed ID: 16604085
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of human African trypanosomiasis.
Van Meirvenne N
Ann Soc Belg Med Trop; 1992; 72 Suppl 1():53-6. PubMed ID: 1417169
[No Abstract] [Full Text] [Related]
33. Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity.
Stephens NA; Hajduk SL
Eukaryot Cell; 2011 Aug; 10(8):1023-33. PubMed ID: 21705681
[TBL] [Abstract][Full Text] [Related]
34. The double-edged sword of evolution.
Kruzel-Davila E; Skorecki K
Elife; 2017 Jul; 6():. PubMed ID: 28671870
[TBL] [Abstract][Full Text] [Related]
35. Adaptation of Trypanosoma rhodesiense to hypohaptoglobinaemic serum requires transcription of the APOL1 resistance gene in a RNA polymerase I locus.
Lecordier L; Uzureau P; Tebabi P; Brauner J; Benghiat FS; Vanhollebeke B; Pays E
Mol Microbiol; 2015 Aug; 97(3):397-407. PubMed ID: 25899052
[TBL] [Abstract][Full Text] [Related]
36. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.
Bullard W; Kieft R; Capewell P; Veitch NJ; Macleod A; Hajduk SL
Virulence; 2012; 3(1):72-6. PubMed ID: 22286709
[TBL] [Abstract][Full Text] [Related]
37. Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1.
Sharma AK; Friedman DJ; Pollak MR; Alper SL
FEBS J; 2016 May; 283(10):1846-62. PubMed ID: 26945671
[TBL] [Abstract][Full Text] [Related]
38. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
39. The use of DNA hybridization and numerical taxonomy in determining relationships between Trypanosoma brucei stocks and subspecies.
Paindavoine P; Pays E; Laurent M; Geltmeyer Y; Le Ray D; Mehlitz D; Steinert M
Parasitology; 1986 Feb; 92 ( Pt 1)():31-50. PubMed ID: 3960593
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
